Related Experiment Video
Updated: Jan 31, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation
Sumei Yao1, Xinming Chen2, Jinliang Chen1
11Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, 6 Haierxiang North Road, Nantong, 226001 Jiangsu People's Republic of China.
Background:
Tumor suppressor epigenetic silencing plays an important role in non-small cell lung cancer (NSCLC) development and progression. Previously, the expression of speckle-type POZ protein (SPOP) has been found to be significantly inhibited in NSCLC. Our research aimed to investigate the molecular mechanisms, clinical significance and epigenetic alteration of SPOP in NSCLC.
Materials And Methods:
Bisulfite sequencing PCR and methylation-specific PCR were performed to test gene methylation. Chromatin immunoprecipitation (ChIP) was performed to detect transcription factor C/EBPα combinations and the promoter of the SPOP gene. Furthermore, we evaluated the effects of C/EBPα siRNA on SPOP expression, tumor cell migration and proliferation via MTT and Transwell assays in vitro and tumor growth in vivo. The relationship between the methylation status of the SPOP gene and clinicopathologic characteristics was investigated.
Results:
Hypermethylation was found in the CpG island of the SPOP gene promoter in NSCLC tissues, and this methylation was found to be correlated with SPOP expression. SPOP promoter methylation was associated with the pathology grade. The transcriptional activities were significantly inhibited by the hypermethylation of specific CpG sites within the SPOP gene promoter, while 5-aza-2'-deoxycytidine significantly increased SPOP gene expression. C/EBPα also played a key role in SPOP regulation. Five C/EBPα binding sites in the CpG island of the SPOP gene promoter were identified by ChIP. Inhibition of C/EBPα significantly reduced SPOP expression. SPOP mediated the C/EBPα-regulated suppression of invasion, migration and proliferation in vitro and tumor growth in vivo.
Conclusions:
SPOP function and expression in NSCLS were regulated by DNA methylation and C/EBPα transcriptional regulation combination effects, indicating that the SPOP promoter methylation status could be utilized as an epigenetic biomarker and that the C/EBPα-SPOP signaling pathway could be a potential therapeutic target in NSCLC.
Insights
Speckle-type POZ protein (SPOP) is silenced in non-small cell lung cancer (NSCLC) by DNA methylation and C/EBPα. This epigenetic silencing presents a potential therapeutic target and biomarker for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Epigenetic silencing of tumor suppressors is crucial in non-small cell lung cancer (NSCLC) development.
- Speckle-type POZ protein (SPOP) expression is notably reduced in NSCLC.
Purpose of the Study:
- To investigate the molecular mechanisms, clinical significance, and epigenetic alterations of SPOP in NSCLC.
- To explore the role of C/EBPα in SPOP regulation and its impact on NSCLC progression.
Main Methods:
- Bisulfite sequencing PCR and methylation-specific PCR to assess gene methylation.
- Chromatin immunoprecipitation (ChIP) to identify transcription factor binding sites.
- In vitro and in vivo assays to evaluate the functional impact of SPOP and C/EBPα modulation.
Main Results:
- SPOP gene promoter hypermethylation was observed in NSCLC tissues, correlating with reduced SPOP expression and higher pathology grade.
- DNA methylation significantly inhibited SPOP transcriptional activity; demethylation reactivated SPOP expression.
- C/EBPα was identified as a key regulator, binding to the SPOP promoter and inhibiting its expression, thereby suppressing tumor invasion, migration, and proliferation.
Conclusions:
- SPOP expression and function in NSCLC are co-regulated by DNA methylation and C/EBPα.
- SPOP promoter methylation status serves as a potential epigenetic biomarker for NSCLC.
- The C/EBPα-SPOP signaling pathway represents a promising therapeutic target for NSCLC treatment.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
From DNA to Protein
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Mechanical Protein Functions

